Multiply Labs Secures $75 Million in Series B Funding for Robotic Drug Manufacturing Expansion
Multiply Labs has successfully raised $75 million in Series B funding aimed at enhancing its robotic systems for automating manual processes in biologics manufacturing. This funding round was led by Dr. Patrick Soon-Shiong and NantWorks, with participation from new investors including AstraZeneca, L...